hpw - topbar hpw - topbar - diag hpw - topbar xce
 

Summer 2018 

Subscribe

Forward to a Friend

Share   

    

View Archived Issues

 
IN THIS ISSUE
 
 

A look at whether value frameworks are the path to implementing value-based pricing, the EMA's move out of the United Kingdom, and the health policy trends in Canada from InnomarLive.

 
 
 

 

 
HTA DECISION MAP
 

When HTA Decisions Occur, We Keep You Informed.

 
 

Xcenda’s HTA Decision Map makes it easy to stay informed. Find out how new products are faring with HTA authorities in:

  • Australia
  • Canada
  • France
  • Germany
  • United Kingdom

 

 

 

 
HEARD ON THE STREET
 

“For the reasons described previously, it is critical that information provided by firms about their unapproved products and about unapproved uses of approved/cleared products be truthful and non-misleading.”

 

Drug and Device Manufacturer Communication with Payors, Formulary Committees, and Similar Entities – FDA guidance for industry and review staff.

Comments regarding requests from payors to receive information from firms about medical products that are not yet approved/cleared by FDA for any use, and about unapproved uses of approved/cleared medical products, so they can plan for and make coverage and reimbursement decisions far in advance of the effective date of such decisions.

 

 

 
HTA BY THE NUMBERS
 

£2.5 Billion

 

The UK has established a £2.5 billion ($3.6 billion) patient capital program to help support the development of British biotechs and high-growth companies into standalone operations. The objective of the fund is to support the development of these firms that would otherwise sell out to international firms.

Source: U.K. creates £2.5B investment program to help startups grow

     
 
GLOBAL REACH. LOCAL EXPERTISE.
 

Gain Global Market Access Insights. Let Our Experts Help.

 
 

Need insights for new geographic markets? Have pressing market access questions that could use the insight of local experts? Then partner with Xcenda and our Global Market Access Network (GMAN) advisors while you’re at ISPOR’s 21st Annual European Congress in Barcelona, Spain. Gain local insights on pricing, reimbursement, and access from this team of global experts.

 

 

 

For more than 2 decades, companies have turned to Xcenda’s leading team of value experts, transforming evidence and market intelligence into effective global market access strategies and solutions. Founded in the application of health outcomes and reimbursement, it’s our goal to help prove the inherent worth of client products and services, maximize patient access, and enhance overall brand performance.

Explore our solutions >

 

 
 

Subscribe to the newsletter written specifically by and for Global HEOR and Market Access professionals.

 
 
 
EDITORS AND CONTRIBUTING AUTHORS
 

EDITOR-IN-CHIEF:
Trent McLaughlin, BSc(Pharm), PhD
Vice President,
Global Health
Economics &
Outcomes Research, Xcenda

MANAGING EDITOR:
Kellie Meyer, PharmD, MPH
Senior Director,
Global Health Economics &
Outcomes Research, Xcenda

 

EDITORIAL BOARD:

Josep Darba, PhD
Professor | Department of Economics | University of Barcelona

George Papadopoulos, BSc(Hons), GradDipEpi
President | Emerald Corporate Group

Ken Redekop, BSc, MPH, PhD
Visiting Associate Professor | National University of Singapore

Eldon Spackman, BA, MA, PhD
Co-Director | Institute for Public Health | University of Calgary

Keith Tolley
Director | Tolley Health Economics

Thomas Mittendorf, MSc, PhD
Managing Director | Xcenda GmbH

Michael Eaddy, PharmD, PhD
Vice President, Scientific Consulting | Xcenda

Jay Jackson, PharmD, MPH
Senior Vice President, Consulting Services | Xcenda

CONTRIBUTING AUTHORS:

Chelsey Campbell, PharmD, MBA, MS | David Campbell, PharmD, MS | Martine Etschmaier, MPH | Minh Luu, MBBS | Kristen Migliaccio-Walle, BS | Roberta Wood, BSc, MBA

PRODUCTION:

Ellen Olson | Laurie Kozbelt | Kylie Matthews

 

Summer 2018

Subscribe

Forward to a Friend

Share   

    

View Archived Issues

 
 

Connect with AmerisourceBergen:   AmerisourceBergen.com   I   LinkedIn   I   Twitter   I   AmerisourceBergen Insights

Connect with Xcenda:   Xcenda.com   I   LinkedIn   I  Twitter

 

 

Copyright © 2018 AmerisourceBergen
Our address is 1800 Innovation Point, Fort Mill, SC 29715, United States

This email was sent on behalf of Xcenda by HealthEconomics.Com, 449 S. Mill View Way, Ponte Vedra Beach, FL 32082.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here , or send your request in writing to the address above. Read more about our privacy policy here. You may also request a copy in writing using the address above.